Loading…

Static and dynamic 18 F-FET PET for the characterization of gliomas defined by IDH and 1p/19q status

The molecular features isocitrate dehydrogenase (IDH) mutation and 1p/19q co-deletion have gained major importance for both glioma typing and prognosis and have, therefore, been integrated in the World Health Organization (WHO) classification in 2016. The aim of this study was to characterize static...

Full description

Saved in:
Bibliographic Details
Published in:European journal of nuclear medicine and molecular imaging 2018-03, Vol.45 (3), p.443
Main Authors: Verger, Antoine, Stoffels, Gabriele, Bauer, Elena K, Lohmann, Philipp, Blau, Tobias, Fink, Gereon R, Neumaier, Bernd, Shah, Nadim J, Langen, Karl-Josef, Galldiks, Norbert
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The molecular features isocitrate dehydrogenase (IDH) mutation and 1p/19q co-deletion have gained major importance for both glioma typing and prognosis and have, therefore, been integrated in the World Health Organization (WHO) classification in 2016. The aim of this study was to characterize static and dynamic O-(2- F-fluoroethyl)-L-tyrosine ( F-FET) PET parameters in gliomas with or without IDH mutation or 1p/19q co-deletion. Ninety patients with newly diagnosed and untreated gliomas with a static and dynamic F-FET PET scan prior to evaluation of tumor tissue according to the 2016 WHO classification were identified retrospectively. Mean and maximum tumor-to-brain ratios (TBR ), as well as dynamic parameters (time-to-peak and slope) of F-FET uptake were calculated. Sixteen (18%) oligodendrogliomas (IDH mutated, 1p/19q co-deleted), 27 (30%) astrocytomas (IDH mutated only), and 47 (52%) glioblastomas (IDH wild type only) were identified. TBR , TBR , TTP and slope discriminated between IDH mutated astrocytomas and IDH wild type glioblastomas (P 
ISSN:1619-7089